Evidence map›Paper›PMID 25237099›Full record

ArticleScience (New York, N.Y.)2014

Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment.

Steven J Shabel, Christophe D Proulx, Joaquin Piriz, Roberto Malinow

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 209 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
209citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06429384 phase2completednot on this mapstarted 2023, after this paper: background citation

Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial -- Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Trial

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2023Enrolled240ConditionsAcute Ischemic StrokeArmsY-3 Injection/Y-3 blank injection
NCT06517173 phase3completednot on this mapstarted 2024, after this paper: background citation

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Y-3 in Chinese Subjects With Acute Ischemic Stroke

TypeinterventionalSponsorBeijing Tiantan HospitalRan2024 to 2025Enrolled998ConditionsAcute Ischemic StrokeArmsY-3 for injection, Placebo control group
3 · Its place in the literature

Who cites it

209 citing papers in PubMed, 2 syntheses or guidelines pooled it, 359 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Dopaminergic hypersensitivity of the opioid-responsive striatal-entopeduncular pathway in a rodent model of restless legs syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Unveiling the 'Eating Poison' ofJournal of pharmaceutical analysis · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

149 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Steven J ShabelCenter for Neural Circuits and Behavior, Department of Neuroscience and Section of Neurobiology, Division of Biology, University of California at San Diego, San Diego, CA, USA. sshabel@gmail.com.
Christophe D ProulxCenter for Neural Circuits and Behavior, Department of Neuroscience and Section of Neurobiology, Division of Biology, University of California at San Diego, San Diego, CA, USA.
Joaquin PirizGrupo de Neurociencia de Sistemas, Instituto de Fisiología y Biofísica Houssay (CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
Roberto MalinowCenter for Neural Circuits and Behavior, Department of Neuroscience and Section of Neurobiology, Division of Biology, University of California at San Diego, San Diego, CA, USA.
Institute of Astronomy and Space Physics · AR

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
A Synaptic Locus Controlling Behavioral DepressionR01MH091119 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALINOW, ROBERTO · 2011 to 2020
$3.9M
NIMH NIH HHS R01 MH091119NINDS NIH HHS NS047101NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

The lateral habenula (LHb), a key regulator of monoaminergic brain regions, is activated by negatively valenced events. Its hyperactivity is associated with depression. Although enhanced excitatory input to the LHb has been linked to depression, little is known about inhibitory transmission. We discovered that γ-aminobutyric acid (GABA) is co-released with its functional opponent, glutamate, from long-range basal ganglia inputs (which signal negative events) to limit LHb activity in rodents. At this synapse, the balance of GABA/glutamate signaling is shifted toward reduced GABA in a model of depression and increased GABA by antidepressant treatment. GABA and glutamate co-release therefore controls LHb activity, and regulation of this form of transmission may be important for determining the effect of negative life events on mood and behavior.

Indexed as

AnimalsAntidepressive AgentsChannelrhodopsinsDepressionEntopeduncular Nucleusgamma-Aminobutyric AcidGlutamate DecarboxylaseGlutamic AcidHabenulaMaleMiceMice, Inbred C57BLNeuronsRatsRats, Sprague-DawleySynaptic TransmissionAntidepressive AgentsChannelrhodopsinsgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1Glutamic AcidSlc17a6 protein, mouseVesicular Glutamate Transport Protein 2

Identifiers

PMID25237099
PMCPMC4305433
OpenAlexW2046270739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.